1. Home
  2. ASYS vs FULC Comparison

ASYS vs FULC Comparison

Compare ASYS & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

N/A

Current Price

$16.47

Market Cap

312.2M

Sector

Technology

ML Signal

N/A

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

N/A

Current Price

$3.78

Market Cap

285.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASYS
FULC
Founded
1981
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.2M
285.4M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
ASYS
FULC
Price
$16.47
$3.78
Analyst Decision
Buy
Hold
Analyst Count
2
5
Target Price
★ $22.50
$3.67
AVG Volume (30 Days)
213.7K
★ 1.2M
Earning Date
08-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.19
N/A
Revenue
★ $79,364,000.00
N/A
Revenue This Year
$8.11
N/A
Revenue Next Year
$39.86
N/A
P/E Ratio
$85.32
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$6.75
$2.83
52 Week High
$25.71
$15.74

Technical Indicators

Market Signals
Indicator
ASYS
FULC
Relative Strength Index (RSI) 53.16 51.35
Support Level $15.89 $3.75
Resistance Level $17.57 $3.91
Average True Range (ATR) 0.63 0.07
MACD 0.09 0.00
Stochastic Oscillator 49.00 52.50

Price Performance

Historical Comparison
ASYS
FULC

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: